Ticker Details
Bristol-Myers Squibb Co. Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals.
IPO Date:	December 31, 1981
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$121.42B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.41 | 0.93%
Avg Daily Range (30 D):	$0.63 | 1.07%
Avg Daily Range (90 D):	$0.53 | 0.94%

Institutional Daily Volume
Avg Daily Volume:	9.43M
Avg Daily Volume (30 D):	8.86M
Avg Daily Volume (90 D):	9.83M

Trade Size
Avg Trade Size (Sh.):	177
Avg Trade Size (Sh.) (30 D):	85
Avg Trade Size (Sh.) (90 D):	92

Institutional Trades
Total Institutional Trades:	129,060
Avg Institutional Trade:	$5.13M
Avg Institutional Trade (30 D):	$13.04M
Avg Institutional Trade (90 D):	$10.42M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	22

Market Closing Trades
Avg Closing Trade:	$57.66M
Avg Closing Trade (30 D):	$167.36M
Avg Closing Trade (90 D):	$140.1M
Avg Closing Volume:	1.08M

News

Apr 10, 2026 @ 10:30 AM 2 Recession Resistant Dividend Stocks to Buy Now W... Source: Prosper Junior Bakiny

Apr 10, 2026 @ 8:59 AM 7MM Systemic Lupus Erythematosus and Lupus Nephrit... Source: Researchandmarkets.Com

Apr 9, 2026 @ 11:00 AM Oxford BioTherapeutics Enters Strategic Collaborat... Source: Oxford Biotherapeutics

Apr 8, 2026 @ 5:00 PM Interstitial Lung Disease Market to Witness Accele... Source: Delveinsight

Apr 6, 2026 @ 5:20 PM Trump Imposes 100% Drug Tariffs: 5 Pharma Stocks T... Source: Jaachi Mbachu, Aci

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$3.47	$.54	$3.47
Diluted EPS	$3.46	$.53	$3.46
Revenue	$48.19B	$12.5B	$48.19B
Gross Profit	$34.26B	$8.41B	$34.26B
Net Income / Loss	$7.06B	$1.09B	$7.06B
Operating Income / Loss	$9.33B	$1.47B	$9.33B
Cost of Revenue	$13.94B	$4.1B	$13.94B
Net Cash Flow	$-129M	$-5508M	$-129M
PE Ratio	16.97